References
- Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Skutle A, Bu ET, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MW, van den Brink W, Moggi F. Risk factors for borderline personality disorder in treatment seeking patients with a substance use disorder: an international multicenter study. Eur Addict Res 2015; 21:188–94.
- Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev 2000; 20:235–53.
- Van Horn DH, Frank AF. Substance-use situations and abstinence predictions in substance abusers with and without personality disorders. Am J Drug Alcohol Abuse 1998; 24:395–404.
- Shen CC, Hu LY, Tsai SJ, Yang AC, Chen PM, Hu YH. Risk stratification for the early diagnosis of borderline personality disorder using psychiatric co-morbidities. Early Intervention Psych 2016. doi:10.1111/eip.12364
- Barrett EL, Newton NC, Teesson M, Slade T, Conrod PJ. Adapting the personality-targeted preventure program to prevent substance use and associated harms among high-risk Australian adolescents. Early Intervention Psych 2015; 9:308–15.
- Tomko RL, Trull TJ, Wood PK, Sher KJ. Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Personality Disorders 2014; 28:734–50.
- Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev 2000; 20:235–53.
- Bornovalova MA, Levy R, Gratz KL, Lejuez CW. Understanding the heterogeneity of BPD symptoms through latent class analysis: initial results and clinical correlates among inner-city substance users. Psychol Assess 2010; 22:233–45.
- Tragesser SL, Jones RE, Robinson RJ, Stutler A, Stewart A. Borderline personality disorder features and risk for prescription opioid use disorders. J Personality Disorders 2013; 27:427–41.
- Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med 2016; 374:363–71.